(Q36669039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Introduction: improving outcomes in chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Foley RN

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

Kidney International. Supplement

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

S1-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17136109%20AND%20SRC:MED&resulttype=core&format=json

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Cardiovascular consequences of renal anaemia and erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001995

7 January 2021